1. Engstrøm, M J, Ytterhus, B, Vatten, L J, Opdahl, S, Bofin, A M. 2014. TOP2A gene copy number change in breast cancer. In Journal of clinical pathology, 67, 420-5. doi:10.1136/jclinpath-2013-202052. https://pubmed.ncbi.nlm.nih.gov/24403186/
2. Järvinen, T A H, Liu, E T. . Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated. In Cytopathology : official journal of the British Society for Clinical Cytology, 14, 309-13. doi:. https://pubmed.ncbi.nlm.nih.gov/14632727/
3. Cai, Hongyu, Zhu, Xinhua, Qian, Fei, Zhang, Yixin, Chen, Zhong. . High expression of TOP2A gene predicted poor prognosis of hepatocellular carcinoma after radical hepatectomy. In Translational cancer research, 9, 983-992. doi:10.21037/tcr.2019.12.46. https://pubmed.ncbi.nlm.nih.gov/35117443/
4. Wang, Ke, Jiang, Xunliang, Jiang, Yu, Li, Jipeng, Zhang, Rui. 2023. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A. In Journal of experimental & clinical cancer research : CR, 42, 320. doi:10.1186/s13046-023-02855-2. https://pubmed.ncbi.nlm.nih.gov/38008711/
5. Nicoś, Marcin, Rolska-Kopińska, Anna, Krawczyk, Paweł, Szczyrek, Michał, Milanowski, Janusz. 2020. Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients. In Archives of medical science : AMS, 17, 474-480. doi:10.5114/aoms.2020.92572. https://pubmed.ncbi.nlm.nih.gov/33747282/
6. Aumayr, Klaus, Klatte, Tobias, Neudert, Barbara, Susani, Martin, Haitel, Andrea. 2017. HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial Carcinomas. In Pathology oncology research : POR, 24, 575-581. doi:10.1007/s12253-017-0260-0. https://pubmed.ncbi.nlm.nih.gov/28755093/
7. Villman, Kenneth, Sjöström, Johanna, Heikkilä, Reino, Saksela, Eero, Blomqvist, Carl. . TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer. In Acta oncologica (Stockholm, Sweden), 45, 590-6. doi:. https://pubmed.ncbi.nlm.nih.gov/16864174/